This project aims to understand the needs of rheumatologists and other specialties in the care of patients with SLE

Trial Identifier:	D3461R00089
Sponsor:	AstraZeneca
NCTID::	NCT06698900
Start Date:	November 2024
Primary Completion Date:	December 2024
Study Completion Date:	December 2024
Condition:	Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil	Sao Paulo, Brazil

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.